Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
Summary
Allogeneic hematopoietic cell transplantation using a myeloablative conditioning regimen may be considered medically necessary as a treatment of chronic myeloid leukemia. Allogeneic hematopoietic cell transplantation using a reduced-intensity conditioning regimen may be considered medically necessary for individuals who meet clinical criteria for an allogeneic HCT but are not considered candidates for a myeloablative conditioning allogeneic HCT, and autologous HCT is investigational for chronic myeloid leukemia. The policy was reviewed 07/27/2026 with policy statements unchanged, and ICD-9 procedure and diagnosis codes were removed from the code reference.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.